| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 327,329 | 279,829 | 388,989 | 428,438 | | Cost of Revenue | 258,176 | 209,689 | 295,706 | 328,819 | | | Gross Profit | 69,153 | 70,140 | 93,283 | 99,619 | | | Operating Expenses | | Research Development | 2,109 | 1,103 | 1,548 | 4,740 | | Selling General and Administrative | 57,099 | 53,935 | 74,169 | 70,619 | | Non Recurring | 407 | (195) | 60,123 | 16,453 | | Others | 9,383 | 10,923 | 14,714 | 15,849 | | | | Total Operating Expenses | 68,998 | 65,766 | 150,554 | 107,661 | | | | Operating Income or Loss | 155 | 4,374 | (57,271) | (8,042) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,188) | (2,829) | 1,141 | (10,576) | | Earnings Before Interest And Taxes | (2,365) | 1,545 | (56,130) | (18,618) | | Interest Expense |
-
| (2,140) | 2,092 | 1,772 | | Income Before Tax | (2,365) | 3,685 | (58,222) | (20,390) | | Income Tax Expense | 1,152 | (15,032) | 1,353 | 6,190 | | Minority Interest | 176 | (1,865) | (822) | 422 | | | | Net Income From Continuing Ops | (3,517) | 16,852 | (60,397) | (26,158) | | | Non-recurring Events | | Discontinued Operations | (140) | (9,621) | (3,039) | (35,828) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,481) | 7,231 | (63,436) | (61,986) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,481) | $7,231 | ($63,436) | ($61,986) |
|
0.51% Nasdaq 
0.01 (0.22%) 
Income Statement
